Company / Net Income
NeoGenomics Laboratories, Inc. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$108.0M
FY2025
5-year range
-$144.3M / -$8.3M
FY2021-FY2025
Trend
-37.2%
vs FY2024
Sector context
#133 of 164
Health Care
What the data says
NeoGenomics Laboratories, Inc.'s net income of -$108M is lower than 81% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$144M in FY2022 to $8M in FY2019.
Based on SEC 10-K filings.
-$108M in FY2025.
Declined from -$88M to -$108M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 164This company -$108.0M Sector average $467.5M
▼
-123.1% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 37.2% year-over-year.
- Ranks #133 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2019.
- Lowest net income in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$108.0M | -37.2% |
| FY2024 | -$78.7M | +10.5% |
| FY2023 | -$88.0M | +39.0% |
| FY2022 | -$144.3M | -1628.2% |
| FY2021 | -$8.3M | -300.1% |
| FY2020 | $4.2M | -47.9% |
| FY2019 | $8.0M | +203.3% |
| FY2018 | $2.6M | +766.7% |
| FY2017 | -$396.0K | +93.6% |
| FY2016 | -$6.1M | -142.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026